Nabriva Therapeutics plc NBRV
1.42 +1.42
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 36.94M | 28.89M | 5.03M | 9.48M | 9.66M | |
| 36.94M | 28.89M | 5.03M | 9.48M | 9.66M | |
| 28.58M | 13.15M | 766.00K | 70.00K | 0 | |
| 8.35M | 15.75M | 4.26M | 9.41M | 9.66M | |
| 63.84M | 64.28M | 70.39M | 88.90M | 124.03M | |
| 14.26M | 12.63M | 15.10M | 26.41M | 82.29M | |
| 45.26M | 51.65M | 55.28M | 62.48M | 41.74M | |
| -55.49M | -48.53M | -66.13M | -79.49M | -114.38M | |
| 698.00K | 901.00K | 1.65M | 3.39M | 133.00K | |
| 1.57M | 490.00K | 139.00K | 101.00K | 49.00K | |
| -57.19M | -49.45M | -69.48M | -82.76M | -114.78M | |
| -57.19M | -49.45M | -69.48M | -82.76M | -114.78M | |
| -57.19M | -49.45M | -69.48M | -82.76M | -114.78M | |
| -57.19M | -49.45M | -69.48M | -82.76M | -114.78M | |
| -2.13 | -2.85 | -13.52 | -27.88 | -56.50 | |
| -2.13 | -2.85 | -13.52 | -27.88 | -56.50 | |
| -2.13 | -2.85 | -13.52 | -27.88 | -56.50 | |
| -54.92M | -48.06M | -67.70M | -79.27M | -114.60M | |
| -54.92M | -48.06M | -67.70M | -79.27M | -114.60M | |
| 2.68M | 1.73M | 513.80K | 296.80K | 203.18K | |
| 2.68M | 1.73M | 513.80K | 296.80K | 203.18K |